Drug Trial Radar · NCT06666179
Safety and Immunogenicity Study of SCB-1019T in Children
Last checked: Nov 20, 2026Latest source record: Dec 31, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Oct 2025
Primary completion
Jun 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Clover Biopharmaceuticals AUS PtyIndustry
- Sponsor type
- Industry
- First posted
- Oct 30, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 24 months, up to 71 months
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This phase 1 study in Australia will evaluate the safety, reactogenicity and immunogenicity of the Bivalent Recombinant Respiratory Syncytial Virus (RSV) Vaccine (CHO Cell) (SCB-1019T) in children 2-\<6 years of age.
Conditions
- RSV Infection
Interventions
low dose SCB-1019TBiological
Bivalent Recombinant Respiratory Syncytial Virus (RSV) Vaccine (CHO Cell) (SCB-1019T)
adjuvanted low dose SCB-1019TBiological
Bivalent Recombinant Respiratory Syncytial Virus (RSV) Vaccine (CHO Cell) (SCB-1019T)
high dose SCB-1019TBiological
Bivalent Recombinant Respiratory Syncytial Virus (RSV) Vaccine (CHO Cell) (SCB-1019T)
adjuvanted high dose SCB-1019TBiological
Bivalent Recombinant Respiratory Syncytial Virus (RSV) Vaccine (CHO Cell) (SCB-1019T)
PlaceboOther
0.9% NaCl saline placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate porportion of participants with solicied AEs of SCB-1019T vaccineTime frame: Within 7 days after vaccination
- Evaluate porportions of participants with unsolicited AEs of SCB-1019T vaccineTime frame: Within 28 days after vaccination
- Evaluate porportions of participants with SAEs, AESIs, MAAEs, AEs leading to early termination from the study of SCB-1019T vaccineTime frame: Throughout the study period, from enrollment to 6 months follow up
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Kids Research Institute
Perth, Western Australia, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.